Bain Capital to Acquire Mitsubishi Tanabe Pharma in $3.3B Carve-Out

February 7, 2025

Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (Tanabe Pharma) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The deal values Tanabe Pharma at approximately 510 billion JPY (~$3.3 billion) and is expected to close in the third quarter of 2025, subject to regulatory clearance and approvals.

Buyers
Bain Capital
Targets
Mitsubishi Tanabe Pharma Corporation
Sellers
Mitsubishi Chemical Group Corporation
Industry
Pharmaceuticals
Location
Osaka, Japan
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.